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Summary
A foldamer has been designed with a conformationally
stiff backbone that is facially amphiphilic. The oligo-
mer has excellent antimicrobial activity and was found
to be 18 times more active toward bacterial cells than
human red blood cells. The oligomer is built from
arylamide bonds around a central 4,6-dicarboxy py-
rimidine ring. The conformation was studied by X-ray
crystallography and solution NMR spectroscopy. Den-
sity-functional (DFT) calculations were performed to
guide the design. These calculations accurately pre-
dicted the overall conformation as well as NMR chem-
ical shifts. Antibacterial activity was demonstrated
against E. coli, a gram-negative strain, and B. subtilis,
a gram-positive strain. The minimal inhibitory concen-
tration is 0.8 mg/ml.
Introduction
Natural polymers, including proteins and RNA, carry out
an impressive array of functions from catalysis and pro-
ton conduction to cell signaling. In all cases, the ability
to perform these operations depends strongly on the
adoption of specific three-dimensional structures. The
essentially unlimited diversity and increased stability
available from synthetic molecules has inspired the
design of nonnatural oligomers that adopt similar struc-
tures [1]. More recently, the ability to endow these
conformationally restricted oligomers with biologically
active properties has been achieved [2–4]. Simple aryla-
mide oligomers and polymers (1) that mimic the overall
physiochemical properties of host defense peptides
like the defensins and magainins were designed [5]. Al-
though these molecules were active toward bacterial
cells, they also had substantial hemolytic activity. We
now describe a new backbone (2) with increased inter-
nal interactions that leads to better selectivity in the kill-
ing of bacterial cells versus human erythrocytes, or red
blood cells (RBCs), compared to the original backbone.
The key structural motif is based on 4,6-dicarboxy
*Correspondence: rjd@olemiss.edu (R.J.D.); tew@mail.pse.umass.
edu (G.N.T.)pyrimidine, as shown in Figure 1, and contains two
new intramolecular hydrogen-heteroatom interactions
compared with the initial arylamide design. Computa-
tional methods, including density functional theory
(DFT), assisted the molecular design of this new back-
bone.
Several groups have reported antimicrobial structures
based on peptides that disrupt phospholipid bilayers,
including b peptides [6–10], peptoids [11], cyclic D,L
nanotubes [12], and linear D,L sequences [13, 14], while
we have focused on abiogenic mimics [15, 16]. These
proteomimetics aim to capture the overall physico-
chemical properties of host defense peptides that are
critical for antimicrobial activity, including, in most
cases, a facially amphiphilic helix in which polar cationic
and nonpolar groups segregate to opposite sides of the
cylinder. This segregation of functionalities onto oppos-
ing faces is a common structural feature of these pep-
tides and is believed to be important for their biological
activity, giving them a strong preference for the water/
lipid interface. In addition, the overall number of cationic
charges and the degree of hydrophobicity is important
for the peptides to discriminate between bacterial and
mammalian cells [17]. This selectivity appears to arise
from significant fundamental differences in bilayer com-
position [17]. Comparing mammalian and bacterial mem-
branes, mammalian cells are known to have a smaller
concentration of negatively charged phospholipids in
the outer leaflet and contain cholesterol, which is known
to reduce peptide activity [18]. Differences in lipid com-
position between these two cell types are also likely to
be important. These natural peptides bind to the outer
membrane leaflet, aggregate, and ultimately cause
pore formation, or loss of membrane integrity, leading
to cell death [17].
The initial study on facially amphiphilic arylamide olig-
omers that were designed as host defense peptide
mimics reported several molecules based on 1,3-dicar-
boxy benzene that were as effective as naturally occur-
ring peptides in killing bacteria [5]. Subsequent work
determined that a discrete oligomer based on backbone
1, but containing only three aromatic rings, could be
designed to have potent antibacterial activity but was
still hemolytic [19]. An additional step to improve the
properties of 1 involved the addition of various side
chains, such as Arg, leading to significant selectivity
for these structures [19].
In contrast to side chain modification, we became
interested in learning how backbone modifications,
including increased conformational stiffness, would im-
pact activity and selectivity. Therefore, we designed a
novel structural analog, also containing three aromatic
rings, in which two aromatic carbons are replaced with
hydrogen bond-accepting nitrogen atoms to give back-
bone 2. This new oligomer is more potent toward bacte-
ria than the compound based on 1, has similar RBC
activity, and is thus more selective. Both crystallography
and solution NMR spectroscopy were used to support
the proposed facially amphiphilic conformation. High-
level computational methods evaluated each interaction
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geometrical parameters of the hydrogen-heteroatom in-
teractions, and the proton chemical shifts. Good agree-
ment was found between the computational predictions
and experimentally determined values. The results
suggest that increased backbone stiffness, due to intra-
molecular interactions, in this class of biomimetic oligo-
mers leads to more active and selective agents.
Results and Discussion
Design
Designing facially amphiphilic structures of nonnatural
oligomers, in which polar and nonpolar groups are posi-
tioned on opposite sides of the two- or three-dimen-
sional structure, requires low-energy conformations
that allow these groups to partition onto different faces
of the molecular structure [1, 5, 15, 20–34]. In the initial
design, based on 1,3-dicarboxy benzene [5], the two
backbone ring-carbonyl single bonds remained rotat-
able, as shown in Figure 1, which could lead to an en-
semble of conformations that incorrectly position the
cationic amine and nonpolar groups. Designing internal
interactions to limit these torsional degrees of freedom
was expected to decrease conformational flexibility
even further and lead to a more active oligomer. One
possible configuration for these interactions was envis-
aged to include two nitrogen atoms ortho to the car-
bonyls (positions 4 and 6), leading to backbone 2, which
is also shown in Figure 1. As a result, we prepared
a novel backbone utilizing N–H$$$S as well as N–H$$$N
interactions and studied two discrete oligomers based
on backbone 2. In addition to the designed interactions,
the oligomer also contains elements of negative design
in which the carbonyls strongly prefer rotation away
from the pyrimidine N atoms. Similar unfavorable inter-
actions between the sulfur atom and carbonyl also con-
tribute to the desired conformation [5, 35, 36], resulting
Figure 1. Oligomer 1 Is Based on 1,3-Dicarboxy Benzene, while the
New Backbone 2 Contains a 4,6-Dicarboxy Pyrimidine
The two additional nitrogen atoms provide new hydrogen bond
acceptors to limit rotation around the aromatic carbon-carbonyl
single bond, which is not confined in 1, as shown by the arrows.in an oligomer whose conformation is restricted by
a combination of positive and negative design elements.
Synthesis
The synthesis of the N-Boc-protected compound 5 is
shown in Figure 2. Oxidation of 4,6-dimethyl-pyrimidine
gave 3 [37], which was then condensed with 4 [5], by
using CDI to yield trimer 5 after purification in 70% yield.
Although some will object that this approach is sloppy,
this synthetic pathway is advantageous because of the
reasonable yield of 5 without multiple protection/depro-
tection steps as well as the simultaneous generation of
pentamer, 6, which was also isolated by column chro-
matography. This pentamer allows us to test directly
the effect of oligomer length on antimicrobial activity
for these new backbones. In addition, intermediates 3
and 4 were used to prepare model compounds 7 [5], 8,
and 9, which are also shown in Figure 2.
Single-Crystal Conformations
X-ray crystallography was used to determine the pres-
ence of internal interactions and study the overall con-
formation of 5. In addition, three model compounds
were prepared in which these hydrogen-heteroatom
interactions were sequentially varied to determine the
influence of each intramolecular interaction separately.
In 5, each amide NH could form an interaction with a
thioether and/or a pyrimidine nitrogen. In 7 [5], the pos-
sibility of a N–H$$$N interaction was removed, leaving
only the N–H$$$S interaction. The opposite is true for
8, which can form the N–H$$$N interaction, but cannot
form the N–H$$$S interaction, while 9 contains no such
internal hydrogen-heteroatom interactions. Single-
crystal structures for all four compounds were obtained.
Figure 3 shows the crystal structure of 5, in which both
the N–H$$$S and N–H$$$N interactions, along with the
calculated low-energy structure, are present. The amide
NHs are involved in three-centered interactions [38],
forming two five-membered hydrogen bonded rings
each. As expected, the amide N–H$$$S interaction
(2.56 A˚) is longer than the N–H$$$N interaction (2.13 A˚)
due to the differences between sulfur and nitrogen.
This leads to a slightly curved conformation, but it
does not affect the facial amphiphilicity of this small olig-
omer. In addition to the interactions, the structure of 5
is as predicted and has a fully extended conformation.
As a result of the extended conformation, the polar
amines and nonpolar groups extend from opposite
sides of the molecule, generating a facially amphiphilic
structure.
For comparison, the crystal structures of 7 and 8,
which each contain one set of interactions, are shown
in Figure 4. Both of these structures are also fully ex-
tended, with N–H$$$S and N–H$$$N interactions averag-
ing 2.50 A˚ and 2.22 A˚, respectively. However, the crystal
structure of 9 is significantly different (Figure 4). The
lack of these intramolecular hydrogen-heteroatom inter-
actions in 9 allows the carbonyls to rotate by 180º; thus,
they point away from each other, resulting in an overall
bent conformation. This rotation might be due to repul-
sive interactions between the carbonyl dipoles, which
are alleviated through the adopted bent structure,
although intermolecular hydrogen bonding and crystal
packing interactions also influence the observed
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429Figure 2. Synthesis of a Pyrimidine-4,6-Dicarboxylic Acid Diamide Foldamer and Other Model Oligomers
(A and B) (A) Synthesis of pyrimidine oligomers 5 and 6 and (B) three model compounds for which crystal structures were obtained in which the
potential for intramolecular interactions was systematically varied. When comparing these structures with 5, compound 7 [5] contains only the
N–H$$$S interaction, 8 possesses only the N–H$$$N interaction, and 9 has all of these intramolecular interactions removed.structure. The ability of 9 to adopt this bent conforma-
tion shows the critical importance of the designed intra-
molecular interactions in the novel facially amphiphilic
oligomers such as 5.
Computational Investigation
Due to the enormous diversity available from nonnatural
sequences, the development and use of computational
methods able to handle these new building blocks and
accurately predict low-energy conformations is critical
[39–50]. Success in this area will lead to greater insight
into the design of nonnatural conformations and guide
experimental effort in a similar manner to the tremen-
dous computational achievements in natural peptide
and protein design. Density functional theory (DFT)
[51, 52] is a computationally efficient method that in-
cludes electron correlation effects with the goal of ob-
taining a reasonably accurate description of hydrogen
bonded molecules [53]. We used DFT to determine ge-
ometries, relative energies, and 1H NMR chemical shifts
of various relevant model compounds. Once the geom-
etries were established, it was possible to gain useful in-
sight into the underlying structural principles governing
the conformation of the target compounds.
The first question we wished to address through com-
putation was the relative stabilizing effect of the N–
H$$$N interaction. A small model compound like 8, but
with only two aromatic rings, 4-pyrimidinecarboxanilide,
was used to compare the two conformations in which
the carbonyl is syn or anti to the ortho pyrimidine N
(see Figure S1 in the Supplemental Data available with
this article online). One conformation has the stabilizing
N–H$$$N interaction, while the other has the destabiliz-ing C]O$$$N interaction. The former structure is lower
in energy by 8.9 kcal/mol. The effect of the N–H$$$N in-
teraction on conformational preference has been noted
previously in experimental work for the case of com-
pounds containing pyridine [22, 26] and pyrimidine rings
[34]. Meanwhile, in earlier work, we examined ortho-
methylthioacetanilide, which has the possibility of an in-
ternal N–H$$$S interaction (also see Figure S1). The N–
H$$$S conformation containing the hydrogen-hetero-
atom interaction was w15 kcal/mol more stable than
the one in which the amide is rotated by 180º, generating
a repulsive C]O$$$S interaction [5, 35]. Though the sta-
bilizing effect of N–H$$$N is not as large as that of N–
H$$$S, each is large enough that 5 will preferentially
contain both of these intramolecular interactions.
Thus, these two stabilizing effects are important for
the design of 5.
In the rest of this report, the computational analysis is
focused on four model compounds that each contain
three aromatic rings. A more complete computational
analysis of the dicarboxy pyrimidine oligomers will be
presented elsewhere (R.J.D. and G.N.T., unpublished
data). The optimized geometries of the four model tri-
mers are shown in Figures 3 and 4. Structure 50, in Fig-
ure 3, corresponds to 5, but it lacks the t-butyl, ethyl
amine, and NH2 groups; 7
0 corresponds to 7, but it has
thioethers attached on the two end rings instead of the
central ring and is also without the t-butyl, ethyl amine,
and NH2 groups; compounds 8 and 9 were considered
explicitly since they already lack the t-butyl and NH2
groups (shown in Figure 4). We were able to establish
the overall conformation of the backbones. For 50, the
final structure does indeed have a planar backbone,
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However, for 70, in sharp contrast to 50, the optimized
structure has a nonplanar backbone. Each amide group
is roughly coplanar with its neighboring thioether ben-
zene ring, but the carbonyls are rotated out of the plane
of the central benzene ring by about 20º, suggesting that
the internal interactions added into 5 are important for
conformational restriction. Meanwhile, the optimized
geometry of 8 is planar. By contrast, planar conforma-
tions of 9 are not true minima, and they are less stable
than nonplanar conformations, such as the one shown
Figure 3. Conformation of Pyrimidine-4,6-Dicarboxylic Acid Di-
amide from X-Ray and Computation
(Top) Crystal structure of 5 showing intramolecular interactions that
confine the molecular conformation to an extended structure plac-
ing polar amine and nonpolar t-butyl groups on opposite faces. The
N–H$$$N distances are 2.08 A˚ and 2.18 A˚, and the amide N–H$$$S
distances are 2.57 A˚ and 2.56 A˚. Atom colors: C, gray; H, white;
N, light blue; O, red; S, yellow. (Bottom) Calculated B3LYP/6-
311G(d,p) lowest-energy conformation for 50. Atom colors: C,
green; H, white; N, blue; O, red; S, yellow. Two different atom color
schemes are used to easily distinguish crystal structures from cal-
culated structures.in Figure 4, by as much as 2 kcal/mol. These calculated
gas-phase structures were compared to the X-ray struc-
tures and to solution NMR data.
Comparison of X-Ray and Calculated Geometries
Comparing the calculated gas-phase structures with
those obtained from X-ray crystallography showed
good agreement for the molecular backbones. For 5
and 50, the backbone is nearly all planar. However,
note that the calculated backbone of 5 is entirely planar
(within w4º), while, in the X-ray structure, the two thio-
ether-substituted rings are not equivalent, with one
turned out of the plane of the backbone by w26º. This
conformational adjustment seems to be caused by the
bulky N-Boc side chain on that ring. By contrast, the
other ring remains coplanar with the backbone, while
the side chain twists around to form a hydrogen bond
between the pyrimidine N and N-Boc amide proton
with an N–H$$$N distance of 2.3 A˚. The influence of
this side chain is also observed on the backbone N–
H$$$N bond distance, which is shorter on that side com-
pared to the other by 0.1 A˚, and on the bond angles.
There is considerable variation in the CCSC dihedral an-
gles, which are 77.5º and 102.3º, due to the formation of
the side chain-pyrimidine hydrogen bond and the twist-
ing of the other thioether side chain out of the way. The
calculated values for 50 were found to lie between these
two extremes at 85.5º. Cis amide structures should also
be much less stable than the trans optimally hydrogen
bonded ones, based on preliminary calculations on
model compounds. Despite these fluctuations, 5 is fully
extended and facially amphiphilic.
In 7 and 70, each amide group is coplanar with the ad-
jacent thioether benzene ring. The amide groups of 8 are
coplanar with the central pyrimidine ring in both the X-
ray and calculated structures, but, in the X-ray structure
of 8, the end benzene rings are rotated out of plane by
w18º, whereas the whole molecule is planar in the cal-
culated, gas-phase structure. In both the calculated
and X-ray structures of 9, the amide groups, one point-
ing up and one pointing down, are twisted out of the
plane of the central benzene ring by about 30º. However,
the X-ray conformation is anti/anti, while the calculatedFigure 4. Conformations of Other Oligomers
from X-Ray and Computation
(Left) Crystal structures for 7, 8, and 9. In
each case, the designed intramolecular in-
teractions are as expected. For 7 and 8, the
N–H$$$S and N–H$$$N intramolecular inter-
actions, respectively, are observed, while
all hydrogen bonding in 9 is intermolecular.
As a result, 9 is able to adopt a bent confor-
mation, unlike compounds 5, 7, and 8. The
two N–H$$$S distances of 7 are 2.46 A˚ and
2.54 A˚, while the pair of N–H$$$N distances
on 8 are 2.25 A˚ and 2.14 A˚. Atom colors: C,
gray; H, white; N, light blue; O, red; S, yellow.
(Right) B3LYP/6-311G(d,p) lowest-energy
conformations for 70, 8, and 9. Atom colors:
C, green; H, white; N, blue; O, red; S, yellow.
Two different atom color schemes are used
to easily distinguish crystal structures from
calculated structures.
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431structure is syn/anti. Overall, the small conformational
differences observed for 7, 8, and 9 likely result from
crystal packing forces, which are absent in the calcu-
lated structures.
Beyond the planarity of the backbone structures, the
computed results agree well with the X-ray conforma-
tions regarding the intramolecular hydrogen bonded
rings that are found. Not surprisingly, though, there are
some relatively minor discrepancies in the geometric
parameters. The bond lengths are very similar (see the
Supplemental Data) (withinw0.01 A˚), except for typical
differences between experimental and DFT predictions
such as the N–H bond lengths, which are usually too
short in X-ray structures, and the S–C bond, which
DFT overestimated by 0.02 A˚. Bond angles for the five-
membered rings are given in Table S6 and show that
the N–H$$$S ring angles average closer to 120º than
those of the N–H$$$N ring for 5. The X-ray bond angles
from the two sides of each compound are nearly the
same, except for the C–N–Hs of 5 and 8, which differ
by as much as 6.1º. Not surprisingly, the DFT structures
predict both sides to be equivalent for 50, 70, and 8. Good
agreement is found between the X-ray and DFT angles;
however, DFT predicts the two C–N–H angles of 50 to be
115.5º 6 0.3º, whereas the X-ray structure of 5 has the
C–N–Hs averaging 115.6º 6 7.7º. This again shows the
strong influence of the thioether side chains in the X-
ray structure of 5. Another interesting thing to note is
the similarity in the N–H$$$S rings of 5 and 7 as well as
the N–H$$$N rings of 5 and 8. Again the only major differ-
ence is for the C–N–H angles, which, in 5, are influenced
by the bulky N-Boc side chains.
Solution Conformations
Amide protons can be monitored by 1H NMR to deter-
mine the influence of solvent composition on chemical
shift. This technique provides insight into the solution
nature of the hydrogen bond and thus into conforma-
tion. For example, a strong intramolecular hydrogen
bonded amide proton would be less sensitive to
changes in solvent composition than a corresponding
amide proton involved in intermolecular or solvent hy-
drogen bonding [28, 54, 55]. Therefore, we monitored
the chemical shift of the amide protons as the solvent
composition was changed from DMSO to CHCl3. Table 1
summarizes the data for compounds 5, 8, and 9. The
amide proton of 9 was found to be very solvent depen-
dent, as expected since all of the NH interactions in
the crystal structure are intermolecular. In fact, not sur-
prisingly, 9 was much less soluble than all of the other
oligomers. Table 1 shows only the two end points; how-
ever, solvent titration experiments were performed on 9
with increasing concentrations of CHCl3 and a steady
up-field shift with increasing CHCl3 concentration was
observed. The amide protons of 8 were also determined
to be solvent sensitive, which was a little surprising
based on the crystal structure. However, these protons
were observed to be slightly less solvent sensitive than
those of 9, although a direct comparison is difficult since
9 is not soluble in neat CHCl3. The change in amide pro-
ton chemical shift for 8 from DMSO to CHCl3 is 1.09 ppm,
similar to that of 9 (0.96 ppm), even though the solution
of 9 in CHCl3 still contains 5% DMSO. The solvent sensi-
tivity of amide protons in 8 may reflect the lowered sta-bility of the five-membered ring compared to the more
common and stable six-membered hydrogen bonded
rings. Similarly, the amide protons of 7 are slightly sen-
sitive to solvent composition (the shift changes by 0.1
ppm when the solution of 7 is changed from DMSO to
20% CDCl3/DMSO).
In contrast to these model systems, the amide pro-
tons of 5 are completely insensitive to solvent composi-
tion. The proton chemical shift was measured to be
11.28 ppm in both neat DMSO and neat CHCl3. A com-
parison of all three structures, 5, 8, and 9, shows that
only in the case where both the N–H$$$S and N–H$$$N
interactions are present is the chemical shift completely
independent of solvent. Thus, the multiple interactions
present in 5 provide more stability, and therefore greater
conformational restriction, than either the N–H$$$S of 7
or the N–H$$$N of 8 alone. These observations are in
agreement with the cooperative three-centered hydro-
gen bonded pattern previously reported [25, 26, 29, 30,
34, 38, 55, 56, 57]. In other work on diaryl amides, the hy-
drogen bond accepter atoms are ether oxygens, form-
ing one six- and one five-membered ring [38]. In another
case, a structure containing two five-membered hydro-
gen bonded rings was reported in which the azine ring is
pyridine, not pyrimidine, and the other side has an ether,
not a thioether; hence, each amide H participates in both
an N–H$$$N and an N–H$$$O hydrogen bond [30].
The recent work on pyrimidines also included pyridine
rings and used pairs of N–H$$$N interations, which
formed five- and four-membered hydrogen bonded
rings [34]. For 5, reported here, two five-membered rings
are formed in which the accepter atoms are sulfur and
nitrogen.
Computational values, also shown in Table 1, support
the observed trends in chemical shift. The calculated
chemical shift of the amide protons for 50 is 11.5 ppm
and, for 8, it is 9.9 ppm. The difference between the cal-
culated gas-phase and experimental CHCl3 values is
only 0.2 and 0.1 ppm for 5/50 and 8, respectively, and,
in both cases, the calculated values are further down-
field than the experimental ones. This is very good
agreement considering that the calculations were per-
formed in the gas phase and that the calculated com-
pound, 50, does not have the extended side chains of
5. By contrast, the calculated chemical shifts for the am-
ide protons of 9 are only 7.4 and 7.7 (the amide Hs are
not equivalent due to the syn/anti conformation). This
large difference of w2 ppm from experiment suggests
that intermolecular hydrogen bonding with solvent is
very important for 9, even in CHCl3. Intermolecular ag-
gregation of 9 was ruled out based on dilution experi-
ments (see the Supplemental Data).
Table 1. 1H NMR Chemical Shifts for the Amide NH
Compound
Chemical
Shift in
DMSO (ppm)
Chemical
Shift in
CHCl3 (ppm)
Calculated
Chemical Shift in
Gas Phase (ppm)
5 11.28 11.28 11.49a
8 10.92 9.83 9.92
9 10.44 9.48b 7.38, 7.69
a For 50.
b 5% DMSO/CHCl3 due to solubility.
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432Table 2. Antibacterial and Hemolytic Activity of Oligomers 10, 11, and 12
MIC mg/ml (mM) Selectivity
Compound E. coli B. subtilis HC50 mg/ml (mM) (HC50/MICE. coli) (HC50/MICB. subtilis)
10 0.8 (1.17) 0.8 14 (20.5) 17.5 17.5
11 12 (17.6) 12 12 (17.6) 1.0 1.0
12 16 (14.7) 16 12 (11.0) 0.75 0.75
The two pyrimidine oligomers are compared directly with 11.Two-dimensional NOESY 1H NMR spectroscopy was
performed on 5 to investigate further the solution con-
formation of this oligomer [28, 58–60]. Strong NOEs
were observed between the amide protons and the
methylenes in the polar side chain, as shown in Figures
S2–S4, yet no signal was observed between the amide
and thioether ring aromatic protons, indicating that the
dominant conformation in solution has the thioether
and amide protons oriented on the same side of the
structure. In addition, NOEs were not observed between
the amide NHs and the aromatic proton ortho to both
carbonyls (2 position) of the pyrimidine, ruling out a non-
facially amphiphilic conformation similar to the bent
structure found for 9 (see the Supplemental Data). As
a result, all NOESY data are consistent with the facially
amphiphilic structure observed by crystallography.
Antimicrobial Activity
After removal of the Boc protecting groups, the amine
salts were screened for antimicrobial activity and hemo-
lysis by using standard protocols for cationic peptidomi-
metics [7, 61–63]. One gram-negative and one gram-
positive organism were used. Compound 10, shown in
Table 2, was found to be highly active and to have a min-
imal inhibitory concentration (MIC) of 0.8 mg/ml against
both E. coli and B. subtilis (Table 2). This is significantly
more active than the deprotected trimer based on 1,
which is also shown in Table 2 as compound 11 [19]. It
is also more active than the Magainin analog, MSI-78,
which has a MIC of 12 mg/ml against this same strain
of E. coli (see the Supplemental Data), and more active
than most host defense peptides as well as their mimics,
which have typical MICs in the range of 5–15 mg/ml [8,
19, 64]. In addition, the HC50 of 10 was determined to
be 14 mg/ml, similar to the value reported for 11 [19].The addition of the two intramolecular interactions cre-
ated by replacing 1,3-dicarboxy benzene with 4,6-dicar-
boxy pyrimidine leads to an oligomer that is more effec-
tive against bacterial cells but has similar activity against
RBCs. As a result, 10 is 18 times more selective than 11
and two times more selective than the highly active MSI-
78, which is 9.6 (see the Supplemental Data) [19, 65]. The
ability to design potency into this small oligomer is very
encouraging for the development of new therapeutic
agents. At the same time, extending the oligomer length
does not yield improved activity or selectivity. In fact, the
amine salt of pentamer 6, compound 12, has a MIC of
16 mg/ml against both bacterial strains and an HC50 of
12 mg/ml. The observation that 10 has maximal activity
and selectivity is consistent with data from our previous
study on urea foldamers [16].
In Vitro Membrane Activity
Hypothesizing that cytoplasmic membrane disruption is
important to the lethal action of these molecules, we ex-
amined the ability of 10 to cause leakage of the osmotic
potential sensitive dye, diSC3-5, fromS. aureus. Figure 5
shows that the fluorescence from the solution contain-
ing diSC3-5-loaded S. aureus increases in a dose-
dependent manner as the concentration of 10 is in-
creased. The increase in fluorescence is consistent with
release of diSC3-5 from the membrane due to loss of the
osmotic potential upon introduction of 1. From this
curve, it is clear that 10 is membrane active against bac-
teria and induces dye leakage at concentrations very
similar to the MIC. Significant leakage around the MIC
is consistent with the activity of natural amphiphilic pep-
tides. Although this experiment confirms the membrane
activity of 10 against living bacteria, it is too early to
implicate membrane disruption as the major cause of
Conformationally Rigid Antimicrobial Agents
433death since protein, RNA, or DNA binding cannot be
ruled out.
Significance
Novel nonnatural sequences have been designed with
intramolecular interactions that lead to an extended
conformation and place polar and nonpolar groups
on opposite faces of the structure. The overriding hy-
pothesis was that stiffening the conformation of the
backbonewould generatemore active andmore selec-
tive compounds. Although a direct measurement con-
necting backbone stiffness to antibacterial potency re-
mains elusive, the newly designed oligomer, 10, is
more active and more selective than 11. By tuning
the oligomer length and intramolecular interactions,
improved selectivity for bacterial cells versus RBCs
was generated for 10. The activity and selectivity of
10 was improved compared to 11; however, the opti-
mal charge density, hydrophobic moment, and spatial
arrangement of charge remain important unanswered
questions to be pursued. Computational methods
were used to guide molecular design and accurately
predicted overall conformation as well as NMR chem-
ical shifts. The conformation of 5 appears to be stabi-
lized by the presence of intramolecular interactions.
These novel sequences combine conformational de-
sign with biological properties. This backbone repre-
sents a robust platform to build shape-specific oligo-
mers, and the potent activity of the short oligomer 10
is encouraging for the generation of new therapeutic
agents to combat the emerging resistance to tradi-
tional antibiotics.
Experimental Procedures
Details of the Experimental Procedures can be found online with the
Supplemental Data.
Computational Procedures
The hybrid density-functional B3LYP was used [66–69] with the rea-
sonably large basis set 6-311G(d,p) [70] for calculating gas-phase
optimized geometries and relative energies. Several possible con-
Figure 5. Dose-Dependent Leakage of the Membrane Potential
Dye, diSC3-5, from S. aureus in the Presence of 10
Significant leakage is observed even at 0.125 times the MIC.formations were considered for each compound. The nature of op-
timized stationary points was checked by calculating harmonic vi-
brational frequencies. Relative stabilities include the zero-point
energy (ZPE), calculated with the same method. The optimized ge-
ometries were used for gauge-including atomic orbital isotropic 1H
NMR chemical shift calculations [71] with the B3P86 [67–69, 72,
73] DFT functional with the 6-31++G(d,p) [70] basis set, which has
been shown to give excellent agreement with experimental solu-
tion-phase chemical shifts of b peptides [47].
All attempts to find a nonplanar structure for 8 minimized back to
the planar structure. Since the amides are attached meta (1,3) on the
benzene ring, each carbonyl can be syn or anti to the central C–H at
the 2-position; this leads to three possible arrangements: syn/syn,
syn/anti; or anti/anti. For the nonplanar structures of 9, the syn/anti
conformations are more stable than the others by 1–2 kcal/mol.
Note that for the structures with thioether side chains, 50 and 70, con-
formations having the two side chains on either the same or oppo-
site sides of the backbone plane are nearly isoenergetic (see the
Supplemental Data). Computational analysis of small model com-
pounds based on a single benzene ring, acetanilide and methyl-
thioacetanilide, was studied previously, and salient points are in-
cluded here for comparison [5, 35, 36]. Additional details on the
computational methods are given in the Supplemental Data.
Supplemental Data
Supplemental Data including details on experimental and computa-
tional procedures, analytical data, ORTEP structures, NMR, and
NOE data are available at http://www.chembiol.com/cgi/content/
full/13/4/427/DC1/.
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